View Article

Abstract

Background: Mimosa pudica L., commonly known as the “touch-me-not” plant, is a creeping, herbaceous species noted for its rapid thigmotactic movement in response to tactile stimuli. Traditionally employed in systems like Ayurveda, Unani, and folk medicine across Asia, Africa, and South America, the plant has been used to manage conditions such as wounds, gastrointestinal disturbances, inflammatory disorders, and reproductive ailments. Its medicinal potential is primarily attributed to a broad array of bioactive phytochemicals. Objective: This review aims to consolidate existing literature on the ethnomedicinal relevance, phytochemical profile, pharmacological activities, cultivation practices, marketed formulations, and patents associated with Mimosa pudica, and to evaluate its scope for future therapeutic applications. Method: A comprehensive search of published articles, patents, and ethnobotanical data was conducted using scientific databases including PubMed, Scopus, and Google Scholar. Information was critically reviewed and categorized under botanical description, traditional use, bioactive constituents, pharmacological activities, and experimental evidence from preclinical studies. Results: Phytochemical screening has identified key compounds such as flavonoids, alkaloids, glycosides, and tannins. Experimental models demonstrated anti-inflammatory, antioxidant, hepatoprotective, wound-healing, and antidiabetic effects using different extracts and plant parts. Several marketed herbal formulations and patented products have incorporated M. pudica, affirming its translational value. Conclusion: Mimosa pudica exhibits diverse pharmacological activities supported by both traditional knowledge and modern scientific validation. Future research should focus on clinical trials, molecular mechanism elucidation, and standardized formulation development to harness its full therapeutic potential.

Keywords

Mimosa pudica L., Traditional Medicine, Phytochemicals, Pharmacological activities, Ethnopharmacology

Introduction

Mimosa pudica L., belonging to the Fabaceae family, is a creeping, herbaceous plant recognized for its rapid response to physical stimuli a unique characteristic that has fascinated botanists for centuries¹. It is believed to have originated in tropical South and Central America but has since spread widely, becoming naturalized in diverse regions of Asia, Africa, Australia, and the Pacific Islands². In India, M. pudica is commonly found in gardens, along roadsides, on wastelands, and in tropical forests. It thrives particularly well in moist, nitrogen-rich soils and disturbed areas, indicating its adaptability to various climatic and soil conditions³. This widespread availability has made the plant easily accessible for use in traditional remedies by rural communities. Botanically, Mimosa pudica is a small, low-growing, thorny shrub that may extend as a ground cover. It typically grows up to 30–50 cm in height. The plant has bipinnate leaves, which fold inward when touched due to a rapid loss of turgor pressure in the pulvini?. Its flowers are small, pink to purplish, and globular, appearing in axillary clusters. It bears small, flat seed pods that break into one-seeded segments when mature. The plant’s pharmacological potential is linked to its rich and diverse phytochemical profile. Various parts of M. pudica including the leaves, roots, and stems have been found to contain alkaloids, flavonoids (such as quercetin), tannins, saponins, terpenoids, glycosides, and steroids?. These bioactive constituents contribute to the plant’s antimicrobial, anti-inflammatory, antioxidant, hepatoprotective, and wound-healing properties?. In terms of harvesting, Mimosa pudica is typically collected manually during its flowering season, which varies by region but often occurs in the monsoon months in tropical areas. Leaves and roots are the most commonly harvested parts for medicinal use. After collection, plant materials are cleaned, shade-dried, and stored in airtight containers to preserve their phytochemical content?. The plant's adaptability to a wide range of environments, ease of propagation through seeds, and low maintenance requirements make it an attractive resource for both traditional use and research-based cultivation. Given its therapeutic promise and ecological abundance, M. pudica holds considerable potential for integration into herbal medicine, nutraceuticals, and even as a model in plant physiology studies.

Taxonomy and Botanical Description

Taxonomy of Mimosa pudica L.

Mimosa pudica L. belongs to the Fabaceae family (also known as Leguminosae), which includes many plants with significant ecological and medicinal value. It is placed under the Mimosoideae subfamily, recognized for its compound leaves and characteristic inflorescence types. The plant’s taxonomic position is outlined below:

Table No. 01 - Taxonomic Classification of Mimosa Pudica L.

Taxonomic Rank

Classification

Kingdom

Plantae

Subkingdom

Tracheobionta (Vascular plants)

Superdivision

Spermatophyta (Seed plants)

Division

Magnoliophyta (Flowering plants)

Class

Magnoliopsida (Dicotyledons)

Order

Fabales

Family

Fabaceae (Leguminosae)

Subfamily

Mimosoideae

Genus

Mimosa

Species

Mimosa pudica L.

The genus name “Mimosa” derives from the Greek word “mimos” meaning mimic, referencing the plant’s ability to react to touch, while “pudica” is Latin for “shy” or “bashful,” reflecting its sensitive nature8

Botanical Description

Mimosa pudica is a small, trailing or low-growing perennial herb, though it often behaves as an annual in temperate climates due to its sensitivity to frost9. It is most notable for its rapid plant movement leaves fold inward and droop when touched or shaken, a defense mechanism known as thigmonasty or seismonasty10.

Table No-02 Summarized Morphological Description

Plant Part

Description

Reference

Habit

Prostrate to ascending herb or subshrub; often forms ground cover

[8]

Height

Typically, 30–50 cm, but can extend longer in creeping form

[8]

Stems

Slender, branching, and often armed with small prickles

[9]

Leaves

Bipinnately compound with 1–2 pairs of pinnae; 10–26 leaflets per pinna; sensitive to touch

[10]

Flowers

Pink to purplish, globular heads; axillary or terminal inflorescences

[9]

Fruit (Pods)

Flat, linear, 1–2 cm long pods with constrictions between seeds

[11]

Seeds

Small, brown, and hard; dispersed via fragmentation of the pod

[11]

The plant prefers sunny to semi-shaded conditions and grows well in moist, well-drained soils. It is commonly found in roadsides, fields, waste areas, and disturbed sites, particularly in tropical and subtropical climates8. Its ability to grow aggressively in open areas and disturbed lands has made it both valuable and, in some areas, invasive. However, this widespread distribution has also contributed to its use in traditional medicine across various regions.

Ethnomedicinal Uses of Mimosa pudica L.

Mimosa pudica L. has been deeply integrated into the traditional medicinal practices of several cultures for centuries. Its use is widespread in Ayurveda, Unani, Siddha, and indigenous healing systems, especially in tropical and subtropical regions where the plant is naturally available?. In Ayurvedic medicine, it is referred to as Lajjalu or Lajjavanti, and is considered to have tikta (bitter) and kashaya (astringent) rasa, with cold potency and kapha-pitta pacifying properties?. The plant is used to address disorders such as dysentery, hemorrhoids, urinary infections, wounds, and female reproductive issues. In folk medicine, M. pudica is frequently used externally as a paste for skin infections, cuts, and insect bites, and internally for gastrointestinal and genitourinary complaints?. Decoctions of the roots or leaves are commonly prepared and consumed orally. Different parts of the plant are utilized for various health conditions, often tailored to the specific cultural or regional medical knowledge. The most commonly used parts include leaves, roots, and seeds, which are used in the form of pastes, decoctions, juices, or powders¹?.

Table No-03 Ethnomedicinal Uses of Mimosa pudica L.

Uses

Plant Part Used

Mode of Application

Traditional System/Region

Reference

Wound healing, cuts

Leaves, roots

Paste applied topically

Ayurveda, rural India

[8]

Diarrhea, dysentery

Leaves

Decoction taken orally

Ayurveda, Unani

[7], [10]

Piles and hemorrhoids

Whole plant

Decoction or powder

Siddha, tribal medicine

[9]

Menstrual disorders

Roots, leaves

Juice or decoction

Folk medicine (India, Nepal)

[11]

Antivenom (snake, scorpion bite)

Roots

Root extract applied orally

Tribal communities (Jharkhand, Odisha)

[12]

Insomnia and anxiety

Whole plant

Decoction before sleep

Ayurveda

[8]

Leucorrhea and urinary issues

Leaves

Infusion or decoction

Unani, rural folk medicine

[13]

Toothache

Leaves

Chewed directly

Traditional Amazonian use

[14]

Thigmonastic Sensitivity in Mimosa pudica: The “Touch-Me-Not” Response

One of the most remarkable features of Mimosa pudica L. is its ability to respond rapidly to touch, vibration, heat, or even sudden darkness. This reaction, commonly referred to as the “touch-me-not” effect, is a type of nastic movement, specifically thigmonasty, which is independent of the direction of the stimulus¹?. When the leaflets of M. pudica are touched, they fold inward and the entire petiole may droop within seconds. This response is thought to be an evolved defensive mechanism, protecting the plant from herbivores or physical damage by making it appear less appealing or alive¹?. The movement originates in specialized structures called pulvini swollen, joint-like regions at the base of leaflets and petioles. These pulvini act like tiny biological motors. Upon stimulation, action potentials (electrical signals) are generated and transmitted rapidly through the plant tissue, particularly along the phloem¹?. These action potentials cause a sudden efflux of potassium (K?) and chloride (Cl?) ions from the pulvinar motor cells into the intercellular spaces. This ionic shift triggers osmotic water loss, resulting in a loss of turgor pressure in the extensor cells, which causes the leaf to fold downward¹?. The entire process happens within 2–3 seconds and resets after a few minutes once the turgor is restored. Interestingly, this touch response can propagate from one leaflet to another and even across multiple branches, making the plant appear “alive” in a reactive sense. The mechanism is considered energy-efficient and is mediated by ATP-dependent ion pumps, although the process does temporarily increase the plant's respiration rate¹?. While this phenomenon is mostly seen in M. pudica, other species within the Mimosoideae subfamily also exhibit similar, though less dramatic, nastic movements. The traditional use of Mimosa pudica has prompted numerous pharmacological investigations, many of which have validated its therapeutic potential. One of the most frequently reported activities is its antimicrobial effect, which has been observed in extracts from leaves, roots, and stems. These extracts have demonstrated inhibitory effects against both Gram-positive and Gram-negative bacterial strains, including Staphylococcus aureus and Escherichia coli, likely due to the presence of flavonoids and tannins. [27] In addition to antimicrobial activity, M. pudica has shown significant anti-inflammatory properties in animal models, particularly in reducing edema and inflammation induced by agents such as carrageenan. [28] The anti-inflammatory response is believed to be mediated through suppression of pro-inflammatory mediators like prostaglandins and cytokines [29]. Moreover, M. pudica possesses antioxidant properties, primarily attributed to its rich flavonoid and polyphenol content. These compounds scavenge free radicals and reduce oxidative stress, which could potentially explain the plant’s protective effect in liver and cardiovascular tissues [30]. Supporting this, hepatoprotective effects have been demonstrated in rodent models where M. pudica extracts significantly restored biochemical markers of liver function following toxin-induced injury [31]. Another important area of pharmacological interest is the plant’s wound healing ability, which has been substantiated in topical application studies. Leaf paste or extract formulations have promoted faster closure of wounds, enhanced epithelialization, and increased collagen deposition, possibly due to the presence of bioactive saponins and alkaloids [32]. Furthermore, recent studies have explored the anxiolytic and sedative potential of the plant, indicating its possible role in central nervous system modulation. Extracts administered orally have been shown to reduce anxiety-like behavior and prolong sleep in experimental animals, suggesting modulation of GABAergic pathways [33]. Emerging evidence also points to antidiabetic and antinociceptive effects of the plant, although more detailed mechanistic and clinical studies are required to confirm these findings. Overall, the breadth of pharmacological activities reported in preclinical studies highlights Mimosa pudica as a multipotent herb with potential applications in modern medicine [34]

Marketed Formulations and Approved Patents

A growing body of commercial interest has emerged around Mimosa pudica, with several formulations now available, particularly in dermo?cosmetic and pharmaceutical markets. One notable example is a topical cream developed by Pierre Fabre in 2021 (US Patent?#10,954,488), which utilizes extracts from undifferentiated Mimosa pudica cells grown in vitro. Proprietary formulations including creams, gels, and emulsions target inflammatory skin conditions, anti-aging, and antioxidant effects for use in polluted environments, with clinical focus on atopic dermatitis, pruritus, eczema, and psoriasis?[35][36]. In pharmaceutical excipient applications, the seed mucilage of M. pudica is patented and marketed for its utility in controlled drug delivery systems. Studies have demonstrated its effectiveness as a natural tablet binder and disintegrant in formulations such as hydrochlorothiazide and paracetamol. Specifically, its hydrophilic and swelling properties allow formulation teams to adjust release profiles, making it a powerful agent in sustained-release drug delivery systems?[37][38] Emerging patents expand the plant's utility in biotech and nanotechnology. For instance, a review highlights the functional applications of chemically modified M. pudica mucilage acetylated, succinylated, or cross-linked for use in stimuli-responsive systems, wound dressings, emulsifiers, and nanoparticle synthesis?[39] These innovations position M. pudica as both a bioactive source and a versatile excipient in modern drug formulation.                 

Table No. 04 - Marketed and Patented Applications of Mimosa pudica L.

Application Area

Formulation Type

Key Features / Uses

Patent/Market Details

Reference

Dermatology & Cosmetics

Topical cream, emulsion

Anti-inflammatory, antioxidant, anti-aging; used for eczema, dermatitis, pruritus

US Patent #10,954,488 by Pierre Fabre; also WO2017216274A2

[35,36]

Pharmaceutical Excipients

Natural binder/disintegrant (tablet)

Used in direct compression tablets; enhances disintegration and drug release

Commercial use in HCTZ and paracetamol tablets

[37]

Sustained Drug Delivery

Matrix tablet (oral SR)

Swelling property controls release rate; suitable for NSAIDs like diclofenac

Preclinical evaluations and pharma-grade applications

[38]

Nanotechnology & Biotech

Modified mucilage (acetylated/succinylated)

Bioadhesive film, wound dressing, nanoparticle stabilizer

Structural modification for smart drug delivery systems

[39]

Mimosa pudica has found diverse applications in modern healthcare and pharmaceutical technology beyond its traditional use. In dermatology and cosmetics, its anti-inflammatory and antioxidant properties are utilized in patented topical formulations for conditions like eczema and dermatitis [35,36] As a pharmaceutical excipient, its natural mucilage serves as an effective binder and disintegrant in tablet formulations, enhancing drug dissolution in products like HCTZ and paracetamol [37] Its swelling behavior also supports the development of sustained-release matrix tablets, particularly for NSAIDs [38] Furthermore, advancements in nanotechnology have enabled the use of chemically modified mucilage from M. pudica in bioadhesive films and nanoparticle delivery systems, showcasing its versatility in innovative drug delivery platforms [39

Table 05: Experimental Evidence of Pharmacological Activities of Mimosa pudica  L.

Pharmacological Activity

Plant Part

Extract / Isolate

Dose / Route

Bioactive Dose

Positive Control

Negative Control

Animals

Experimental Model & Parameters

Mechanism of Action

Inference

Reference

Aphrodisiac

Roots

Ethanolic extract

100–500?mg/kg p.o., 7 days

500?mg/kg

Sildenafil citrate

Vehicle

Swiss albino male mice (n=6/group)

Libido scoring, testosterone levels

Hormonal modulation (↑ testosterone)

Effective libido enhancer at 500?mg/kg with no adverse effect

[40]

Anticonvulsant

Roots

Ethanolic extract

1000, 2000?mg/kg p.o.

2000?mg/kg

Valproate

Vehicle

Swiss albino mice

MES & PTZ models: seizure latency, tonic hind-limb extension, clonus

CNS depression; raises seizure threshold

Significant anticonvulsant activity demonstrated

[41]

Antidepressant

Leaves

Ethanolic extract

4–8?mg/kg i.p.; also 100–400?mg/kg p.o.

6?mg/kg (i.p.), 200?mg/kg p.o.

Imipramine

Saline

Swiss albino mice (n=6/group)

TST & FST immobility duration

Modulation of central neurotransmission

Demonstrated comparable antidepressant effect to imipramine

[42]

Anti-inflammatory

Whole plant

Hydroalcoholic extract

200–800?mg/kg p.o.

400?mg/kg

Aspirin

Vehicle

Albino rats (n=6/group)

Carrageenan-induced paw edema volume

Inhibition of inflammatory mediators

Significant anti-inflammatory activity confirmed

[43]

Wound?healing & Antidiabetic

Seeds

Ethyl acetate & ethanolic extracts

100–400?mg/kg p.o. daily

400?mg/kg

Vehicle

STZ?induced diabetic rats

Wound contraction rate, blood glucose, histopathology on day?15

Blood glucose reduction, collagen deposition, antioxidant effects

Marked wound healing and glucose-lowering in diabetic rats

[44]

Antidiabetic & Renoprotective

Leaves (fraction)

Ethyl?acetate fraction

50 & 100?mg/kg p.o. for 60 days

100?mg/kg

Vehicle

STZ?induced diabetic mice

OGTT, lipid profile, kidney histology, antioxidant enzymes, cytokine levels

↑ SOD/CAT/GPx, ↓ MDA, IL?1β, TNF?α; improved nephron integrity

Demonstrated antihyperglycemic and kidney-protective effects

[45]

Antifertility

Roots

Methanol extract

300?mg/kg p.o. daily for 21 days

300?mg/kg

Vehicle

Swiss albino female mice

Estrous cycle monitoring, hormone assays, litter count

Hormonal disruption: ↓ FSH, altered estrous cycle

Significant antifertility potential demonstrated

[46]

Mimosa pudica has been extensively studied in various experimental models to validate its traditional uses and reveal its pharmacological potential. Recent studies have demonstrated significant activities across several therapeutic domains, highlighting its promise as a source of bioactive compounds.

Aphrodisiac Activity: The root extract of Mimosa pudica has been shown to enhance sexual behavior in male mice, indicating aphrodisiac properties. Sharma et al. (2010) reported that administration of the root extract increased mount frequency and penile reflexes, suggesting a positive modulation of reproductive functions likely mediated through androgenic pathways [40]

Anticonvulsant Activity: Chatterjee et al. (2011) evaluated the anticonvulsant effects of the root extract using chemically induced seizure models in Swiss albino mice. The extract significantly delayed the onset of seizures and reduced their severity, comparable to standard anticonvulsant drugs. This suggests that phytoconstituents of M. pudica may modulate neurotransmitter systems or ion channels involved in seizure activity [41]

Antidepressant-like Effects: Rathor and Mehta (2016) explored the antidepressant potential of Mimosa pudica leaf extracts in rodent behavioral models such as the forced swim and tail suspension tests. The extracts produced a significant reduction in immobility time, indicative of antidepressant-like activity. This effect may be linked to the modulation of monoaminergic neurotransmission [42]

Anti-inflammatory Activity: Anti-inflammatory properties of Mimosa pudica have been validated by Mehta et al. (2014), who demonstrated that hydroalcoholic leaf extracts reduce paw edema induced by carrageenan in albino rats. The extract inhibited the release of pro-inflammatory mediators, possibly through suppression of cyclooxygenase and lipoxygenase pathways [43] Wound Healing and Antidiabetic Effects: Maurya et al. (2015) assessed the wound healing and antidiabetic potential of Mimosa pudica seed extract in streptozotocin-induced diabetic rats. The extract accelerated wound contraction and epithelialization, while also improving glycemic control and antioxidant status. These dual effects suggest its use in managing diabetic wounds through combined metabolic and tissue repair mechanisms [44].

Renoprotective and Antioxidant Effects: Khandelwal et al. (2018) investigated the leaf fraction’s effect on kidney function in diabetic mice. Treatment with the extract improved renal biomarkers and reduced oxidative stress markers, indicating a protective effect against diabetic nephropathy. The antioxidant properties are attributed to flavonoids and phenolic compounds present in the plant [45]

Cultivation, Seeding, and Harvesting of Mimosa pudica

Mimosa pudica is a hardy, fast-growing herbaceous plant that adapts well to diverse environmental conditions, making its cultivation relatively straightforward. Understanding proper cultivation practices is essential to ensure the availability of quality plant material for medicinal and research uses.

Seed Propagation and Germination

The primary propagation method of Mimosa pudica is through seeds, which are small, brown, and enclosed in linear pods that fragment upon maturity to facilitate dispersal. To improve germination rates, seeds are often scarified or soaked in water for 12–24 hours to soften the hard seed coat and break dormancy. Under optimal conditions, seeds typically germinate within 7 to 14 days [47] Seeds are sown directly into well-prepared seedbeds or nursery trays filled with light, well-drained soil enriched with organic matter. The ideal soil pH ranges between 5.5 and 7.5, and consistent moisture is maintained to support healthy seedling emergence [48]

Soil and Climatic Requirements

Mimosa pudica thrives in tropical and subtropical climates with warm temperatures ranging from 20–35°C and moderate to high humidity. It prefers sunny to semi-shaded environments and grows well in disturbed, nitrogen-rich soils such as loamy, sandy, or clay soils, provided they are well-drained. While drought tolerant once established, regular irrigation during dry spells promotes optimal growth [49]

Transplanting and Field Cultivation

Seedlings are typically transplanted to the main field after 3 to 4 weeks in the nursery, when they reach 5–7 cm in height. Recommended plant spacing is 30–50 cm to allow adequate growth and air circulation, minimizing disease incidence. Due to its creeping habit, Mimosa pudica can serve as effective ground cover and helps in soil erosion control (50)

Nutrient Management and Pest Control

Although the plant can grow in nutrient-poor soils, applying organic compost or balanced fertilizers rich in nitrogen, phosphorus, and potassium enhances biomass and phytochemical production. The plant is relatively resistant to pests but may occasionally be affected by aphids, mites, or fungal pathogens. Use of integrated pest management (IPM) with minimal chemical intervention is advised to preserve the plant’s medicinal quality [51]

Harvesting Practices

Harvesting is usually done during the flowering phase, which coincides with monsoon or post-monsoon months in tropical regions. Leaves and aerial parts are collected by hand early in the morning when phytochemical levels are highest. Roots are harvested carefully from mature plants when required. Post-harvest, plant materials are cleaned, shade-dried under ambient conditions, and stored in airtight containers protected from light and moisture to maintain their pharmacological potency [52]

Fig No. 01 - Cultivating Mimosa pudica L. Step by step Guide

Future Prospects of Mimosa pudica L.

Mimosa pudica holds considerable promise for future research and development due to its unique biological properties, wide-ranging pharmacological activities, and ecological adaptability. Several avenues present themselves for further exploration and application:

  1. Phytochemical and Pharmacological Exploration

While many bioactive compounds like flavonoids, alkaloids, tannins, and terpenoids have been identified, advanced techniques such as metabolomics, proteomics, and genomics could uncover novel phytochemicals with potent therapeutic effects. Isolating and characterizing these compounds may lead to new drug candidates for antimicrobial, anti-inflammatory, antioxidant, and neuroprotective applications. Furthermore, detailed mechanism of action studies at the molecular and cellular levels can enhance understanding of how M. pudica extracts exert their biological effects, potentially improving efficacy and safety profiles in clinical contexts.

2. Development of Standardized Herbal Formulations

To facilitate mainstream acceptance, efforts must be made to develop standardized, quality-controlled herbal products derived from M. pudica. This includes establishing robust cultivation protocols, optimizing extraction methods, and validating bioactive marker compounds for quality assurance. Such standardized formulations could be incorporated into nutraceuticals, topical agents for wound healing, or adjunct therapies for gastrointestinal and inflammatory disorders.

3. Biotechnological and Agronomic Advances

Biotechnological approaches such as tissue culture, genetic engineering, and molecular breeding may improve the yield, phytochemical content, and stress resistance of M. pudica. This could enable large-scale, sustainable production with consistent quality. Additionally, agronomic studies focused on optimizing growth conditions, pest management, and post-harvest processing will support commercial cultivation efforts.

4. Environmental and Ecological Applications

Given its rapid growth and soil-binding capabilities, Mimosa pudica could be further explored for use in soil erosion control, land reclamation, and phytoremediation projects. Its resilience in disturbed environments makes it a candidate for ecological restoration initiatives in degraded landscapes.

5. Clinical Research and Therapeutic Validation

Currently, most evidence for M. pudica’s medicinal properties is preclinical. Conducting well-designed clinical trials is essential to validate safety and efficacy in humans, establish dosage regimens, and explore potential drug interactions. Such research could pave the way for formal approval and incorporation of M. pudica derivatives into conventional medicine.

CONCLUSION

Mimosa pudica L., widely known as the “touch-me-not” plant, stands out not only for its remarkable thigmonastic movements but also for its significant therapeutic potential recognized across traditional medicinal systems worldwide. The plant’s adaptability to diverse climatic conditions and its ease of propagation contribute to its accessibility and sustainable use in various regions, especially tropical and subtropical areas. Phytochemical investigations have revealed a rich spectrum of bioactive compounds in M. pudica, including alkaloids, flavonoids, tannins, terpenoids, and glycosides, which underpin its broad pharmacological profile. Experimental studies validate its antimicrobial, anti-inflammatory, antioxidant, hepatoprotective, and wound healing properties, among others, supporting its traditional applications for gastrointestinal disorders, skin infections, reproductive health, and neurological conditions. The integration of M. pudica in ethnomedicine is extensive, reflecting centuries of accumulated indigenous knowledge. However, modern scientific scrutiny has only begun to unravel the molecular mechanisms governing its pharmacological actions. Studies indicate that the plant’s bioactive constituents exert effects through multiple pathways, including modulation of oxidative stress, inflammatory mediators, and microbial inhibition. From an agronomic perspective, M. pudica is a resilient species that thrives in disturbed soils and can be cultivated with relatively simple techniques. Proper seed treatment, optimal soil management, and timely harvesting are essential to maintain the quality and efficacy of the plant material used for medicinal purposes. Marketed herbal formulations based on Mimosa pudica and emerging patented products underscore its commercial and therapeutic potential. Nonetheless, gaps remain in standardization, quality control, and comprehensive clinical evaluation, which are crucial for its acceptance in mainstream therapeutics. Looking ahead, advances in biotechnology, pharmacology, and clinical research are poised to unlock new applications for M. pudica. Its unique properties also position it as a valuable candidate for environmental restoration and sustainable agriculture. In summary, Mimosa pudica exemplifies a plant with rich traditional heritage and promising modern relevance. Bridging ethnopharmacological wisdom with rigorous scientific validation will be vital to harness its full potential for health care and ecological benefits globally.

REFERENCES

  1. Tiwari A, Singh D. Sensitive plant (Mimosa pudica): A review on its therapeutic significance. International Journal of Pharmaceutical Sciences Review and Research. 2011;8(2):120–124.
  2. Barros T, Soares R, de Oliveira T. Global distribution and ecological spread of Mimosa pudica: A review. Journal of Environmental Biology. 2017;38(5):1079–1084.
  3. Khan MR, Rizvi W. Availability and ethnobotanical relevance of Mimosa pudica in India. Indian Journal of Traditional Knowledge. 2013;12(2):389–395.
  4. Mahajan S, Chopade B. Biological overview of Mimosa pudica and its thigmonastic movement. Botanical Review. 2010;76(3):347–358.
  5. Dey P, Debnath PK. Phytochemical and pharmacological studies on Mimosa pudica L. Pharmacognosy Reviews. 2016;10(19):47–52.
  6. Chakraborty R, Devi RK. A review on the pharmacological aspects of Mimosa pudica. International Journal of Green Pharmacy. 2014;8(2):74–80.
  7. Patel J, Patel R, Suthar M. Harvesting and processing of medicinal plants: An overview with Mimosa pudica as a case study. International Journal of Herbal Medicine. 2019;7(6):01–06.
  8. Gledhill D. The Names of Plants. 4th ed. Cambridge: Cambridge University Press; 2008.
  9. Barros T, Soares R, de Oliveira T. Global distribution and ecological spread of Mimosa pudica: A review. J Environ Biol. 2017;38(5):1079–84.
  10. Mahajan S, Chopade B. Biological overview of Mimosa pudica and its thigmonastic movement. Bot Rev. 2010;76(3):347–58.
  11. Singh N, Raghavendra MP. A botanical study of Mimosa pudica Linn. Int J Botany Stud. 2020;5(3):15–9.
  12. Dey P, Debnath PK. Phytochemical and pharmacological studies on Mimosa pudica L. Pharmacogn Rev. 2016;10(19):47–52.
  13. Patel J, Patel R, Suthar M. Harvesting and processing of medicinal plants: An overview with Mimosa pudica as a case study. Int J Herbal Med. 2019;7(6):1–6.
  14. Choudhury MD, Nath D, Talukdar AD. A review on the ethnobotany and pharmacology of Mimosa pudica Linn. J Pharm Res. 2013;6(4):420–4.
  15. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants Used in Ayurveda. Vol. 4. New Delhi: CCRAS; 2005.
  16. Kala CP, Dhyani PP, Sajwan BS. Developing the medicinal plants sector in northern India: Challenges and opportunities. J Ethnobiol Ethnomed. 2006;2:32.
  17. Das S, Das U, Roy D. Pharmacological potentials of Mimosa pudica—A concise review. J Pharmacogn Phytochem. 2016;5(3):45–8.
  18. Joshi SG. Medicinal Plants. New Delhi: Oxford and IBH Publishing; 2000.
  19. Rai MK, Acharya D. Indigenous knowledge and traditional healing practices in tribal communities of central India. Indian J Tradit Knowl. 2011;10(3):408–13.
  20. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New York: Springer; 2007.
  21. Plotkin MJ. Medicine Quest: In Search of Nature’s Healing Secrets. New York: Viking; 2000.
  22. Fleurat-Lessard P, Frangne N, Maeshima M, Ratajczak R, Bonnemain JL, Martinoia E. Increased expression of vacuolar aquaporins during thigmonastic movements in Mimosa pudica. Plant Physiol. 1997;114(3):827–34.
  23. Satter RL, Galston AW. Pulvinus: Motor Organ for Leaf Movement. In: Encyclopedia of Plant Physiology. Berlin: Springer; 1981. p. 641–90.
  24. Volkov AG, Foster JC, Ashby TA, Walker RK, Johnson JA, Markin VS. Mimosa pudica: electrical and mechanical stimulation of plant movements. Plant Cell Environ. 2010;33(2):163–73.
  25. Braam J. In touch: plant responses to mechanical stimuli. New Phytol. 2005;165(2):373–89.
  26. Samejima M, Sibaoka T. Changes in respiration and ATP levels in the pulvini of Mimosa pudica during seismonastic movement. Plant Cell Physiol. 1980;21(3):467–78.
  27. Gupta A, Malhotra B, Tripathi A. Antibacterial efficacy of Mimosa pudica leaf extract on selected human pathogens. J Ethnopharmacol. 2020;259:112940.
  28. Kumar V, Singh G, Kaur J. Anti-inflammatory potential of Mimosa pudica L. extract in carrageenan-induced rat paw edema. J Pharm Investig. 2019;49(1):49–55.
  29. Das S, Paul D. Modulation of cytokine levels by bioactive components of Mimosa pudica in inflammation models. Int J Green Pharm. 2017;11(4):842–7.
  30. Roy A, Sengupta S. Antioxidant profiling and phenolic quantification of Mimosa pudica leaves. Free Radic Antioxid. 2018;8(1):20–5.
  31. Sharma N, Verma PK. Evaluation of hepatoprotective activity of Mimosa pudica root extract against paracetamol-induced liver toxicity. J Tradit Complement Med. 2021;11(2):190–6.
  32. Jain A, Mishra A. Wound healing potential of Mimosa pudica: A preclinical study. Phytomed Plus. 2022;2(3):100276.
  33. Patel M, Solanki R. Anxiolytic and sedative effects of Mimosa pudica extract in Swiss albino mice. J Pharmacol Pharmacother. 2018;9(2):85–9.
  34. Bhowmik D, Chandira M. A comprehensive review on pharmacological activities of Mimosa pudica Linn. Int J PharmTech Res. 2020;13(4):295–302.
  35. Pierre Fabre Dermo-Cosmétique. US Patent No. 10,954,488. Topical use of Mimosa pudica extracts. 2021.
  36. Same patent family: WO2017216274A2, KR102507491B1.
  37. Ahuja M, Kumar A, Yadav M. Evaluation of Mimosa pudica seed mucilage as excipient. Int J Biol Macromol. 2013;57:105–110.
  38. Singh K, Sharma V, Garg A. M. pudica mucilage-based sustained release matrix tablet. AAPS PharmSciTech. 2009;10(4):1121–1127.
  39. Meena A, Tiwari S, Bhatt G. Structural modification of M. pudica mucilage for drug delivery applications. Int J Biol Macromol. 2024;270:132390.
  40. Sharma A, Thakur M, Chauhan NS, Dixit VK. Evaluation of the aphrodisiac activity of Mimosa pudica Linn. root extract in male mice. Pharmacologyonline. 2010;2:591–598.
  41. Chatterjee S, Variyar P, Sharma A. Anticonvulsant activity of Mimosa pudica root extract in Swiss albino mice. Int J Pharm Sci Res. 2011;2(12):3195–3200.
  42. Rathor RS, Mehta S. Evaluation of antidepressant-like activity of Mimosa pudica Linn. in animal models. Asian J Pharm Clin Res. 2016;9(3):158–161.
  43. Mehta M, Kumawat K, Kaushik S. Anti-inflammatory activity of hydroalcoholic extract of Mimosa pudica in albino rats. Int J Pharm Biol Sci. 2014;5(1):60–65.
  44. Maurya R, Arya S, Kumar A. Wound healing and antidiabetic potential of Mimosa pudica seed extract in streptozotocin-induced diabetic rats. J Diabetes Metab Disord. 2015;14:24.
  45. Khandelwal S, Singh DP, Singh S. Protective effect of Mimosa pudica leaf fraction on kidney function and oxidative stress in diabetic mice. Biomed Pharmacother. 2018;103:385–390.
  46. Thakur A, Joshi A, Chauhan NS, Dixit VK. Antifertility effects of methanolic root extract of Mimosa pudica Linn. in female albino mice. J Ethnopharmacol. 2009;124(3):563–567.
  47. Sharma R, Singh P. Seed treatment and germination improvement techniques for medicinal plants. J Herbal Agric Sci. 2021;8(2):78–85.
  48. Gupta M, Yadav S. Soil and climatic factors influencing growth of Mimosa pudica. Int J Plant Sci. 2020;12(1):45–51.
  49. Patel R, Joshi V. Cultivation practices for medicinal herbs in tropical regions. Herbal Res J. 2022;10(4):120–128.
  50. Kumar S, Singh D. Propagation and field management of Mimosa pudica for sustainable use. Agric Sci Rev. 2019;15(3):200–207.
  51. Rao A, Das N. Integrated pest management in medicinal plant cultivation. J Plant Protect Sci. 2020;16(1):30–37.
  52. Mehta K, Sharma N. Post-harvest processing and storage of medicinal herbs. Phytomed J. 2021;7(2):95–102.

Reference

  1. Tiwari A, Singh D. Sensitive plant (Mimosa pudica): A review on its therapeutic significance. International Journal of Pharmaceutical Sciences Review and Research. 2011;8(2):120–124.
  2. Barros T, Soares R, de Oliveira T. Global distribution and ecological spread of Mimosa pudica: A review. Journal of Environmental Biology. 2017;38(5):1079–1084.
  3. Khan MR, Rizvi W. Availability and ethnobotanical relevance of Mimosa pudica in India. Indian Journal of Traditional Knowledge. 2013;12(2):389–395.
  4. Mahajan S, Chopade B. Biological overview of Mimosa pudica and its thigmonastic movement. Botanical Review. 2010;76(3):347–358.
  5. Dey P, Debnath PK. Phytochemical and pharmacological studies on Mimosa pudica L. Pharmacognosy Reviews. 2016;10(19):47–52.
  6. Chakraborty R, Devi RK. A review on the pharmacological aspects of Mimosa pudica. International Journal of Green Pharmacy. 2014;8(2):74–80.
  7. Patel J, Patel R, Suthar M. Harvesting and processing of medicinal plants: An overview with Mimosa pudica as a case study. International Journal of Herbal Medicine. 2019;7(6):01–06.
  8. Gledhill D. The Names of Plants. 4th ed. Cambridge: Cambridge University Press; 2008.
  9. Barros T, Soares R, de Oliveira T. Global distribution and ecological spread of Mimosa pudica: A review. J Environ Biol. 2017;38(5):1079–84.
  10. Mahajan S, Chopade B. Biological overview of Mimosa pudica and its thigmonastic movement. Bot Rev. 2010;76(3):347–58.
  11. Singh N, Raghavendra MP. A botanical study of Mimosa pudica Linn. Int J Botany Stud. 2020;5(3):15–9.
  12. Dey P, Debnath PK. Phytochemical and pharmacological studies on Mimosa pudica L. Pharmacogn Rev. 2016;10(19):47–52.
  13. Patel J, Patel R, Suthar M. Harvesting and processing of medicinal plants: An overview with Mimosa pudica as a case study. Int J Herbal Med. 2019;7(6):1–6.
  14. Choudhury MD, Nath D, Talukdar AD. A review on the ethnobotany and pharmacology of Mimosa pudica Linn. J Pharm Res. 2013;6(4):420–4.
  15. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants Used in Ayurveda. Vol. 4. New Delhi: CCRAS; 2005.
  16. Kala CP, Dhyani PP, Sajwan BS. Developing the medicinal plants sector in northern India: Challenges and opportunities. J Ethnobiol Ethnomed. 2006;2:32.
  17. Das S, Das U, Roy D. Pharmacological potentials of Mimosa pudica—A concise review. J Pharmacogn Phytochem. 2016;5(3):45–8.
  18. Joshi SG. Medicinal Plants. New Delhi: Oxford and IBH Publishing; 2000.
  19. Rai MK, Acharya D. Indigenous knowledge and traditional healing practices in tribal communities of central India. Indian J Tradit Knowl. 2011;10(3):408–13.
  20. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New York: Springer; 2007.
  21. Plotkin MJ. Medicine Quest: In Search of Nature’s Healing Secrets. New York: Viking; 2000.
  22. Fleurat-Lessard P, Frangne N, Maeshima M, Ratajczak R, Bonnemain JL, Martinoia E. Increased expression of vacuolar aquaporins during thigmonastic movements in Mimosa pudica. Plant Physiol. 1997;114(3):827–34.
  23. Satter RL, Galston AW. Pulvinus: Motor Organ for Leaf Movement. In: Encyclopedia of Plant Physiology. Berlin: Springer; 1981. p. 641–90.
  24. Volkov AG, Foster JC, Ashby TA, Walker RK, Johnson JA, Markin VS. Mimosa pudica: electrical and mechanical stimulation of plant movements. Plant Cell Environ. 2010;33(2):163–73.
  25. Braam J. In touch: plant responses to mechanical stimuli. New Phytol. 2005;165(2):373–89.
  26. Samejima M, Sibaoka T. Changes in respiration and ATP levels in the pulvini of Mimosa pudica during seismonastic movement. Plant Cell Physiol. 1980;21(3):467–78.
  27. Gupta A, Malhotra B, Tripathi A. Antibacterial efficacy of Mimosa pudica leaf extract on selected human pathogens. J Ethnopharmacol. 2020;259:112940.
  28. Kumar V, Singh G, Kaur J. Anti-inflammatory potential of Mimosa pudica L. extract in carrageenan-induced rat paw edema. J Pharm Investig. 2019;49(1):49–55.
  29. Das S, Paul D. Modulation of cytokine levels by bioactive components of Mimosa pudica in inflammation models. Int J Green Pharm. 2017;11(4):842–7.
  30. Roy A, Sengupta S. Antioxidant profiling and phenolic quantification of Mimosa pudica leaves. Free Radic Antioxid. 2018;8(1):20–5.
  31. Sharma N, Verma PK. Evaluation of hepatoprotective activity of Mimosa pudica root extract against paracetamol-induced liver toxicity. J Tradit Complement Med. 2021;11(2):190–6.
  32. Jain A, Mishra A. Wound healing potential of Mimosa pudica: A preclinical study. Phytomed Plus. 2022;2(3):100276.
  33. Patel M, Solanki R. Anxiolytic and sedative effects of Mimosa pudica extract in Swiss albino mice. J Pharmacol Pharmacother. 2018;9(2):85–9.
  34. Bhowmik D, Chandira M. A comprehensive review on pharmacological activities of Mimosa pudica Linn. Int J PharmTech Res. 2020;13(4):295–302.
  35. Pierre Fabre Dermo-Cosmétique. US Patent No. 10,954,488. Topical use of Mimosa pudica extracts. 2021.
  36. Same patent family: WO2017216274A2, KR102507491B1.
  37. Ahuja M, Kumar A, Yadav M. Evaluation of Mimosa pudica seed mucilage as excipient. Int J Biol Macromol. 2013;57:105–110.
  38. Singh K, Sharma V, Garg A. M. pudica mucilage-based sustained release matrix tablet. AAPS PharmSciTech. 2009;10(4):1121–1127.
  39. Meena A, Tiwari S, Bhatt G. Structural modification of M. pudica mucilage for drug delivery applications. Int J Biol Macromol. 2024;270:132390.
  40. Sharma A, Thakur M, Chauhan NS, Dixit VK. Evaluation of the aphrodisiac activity of Mimosa pudica Linn. root extract in male mice. Pharmacologyonline. 2010;2:591–598.
  41. Chatterjee S, Variyar P, Sharma A. Anticonvulsant activity of Mimosa pudica root extract in Swiss albino mice. Int J Pharm Sci Res. 2011;2(12):3195–3200.
  42. Rathor RS, Mehta S. Evaluation of antidepressant-like activity of Mimosa pudica Linn. in animal models. Asian J Pharm Clin Res. 2016;9(3):158–161.
  43. Mehta M, Kumawat K, Kaushik S. Anti-inflammatory activity of hydroalcoholic extract of Mimosa pudica in albino rats. Int J Pharm Biol Sci. 2014;5(1):60–65.
  44. Maurya R, Arya S, Kumar A. Wound healing and antidiabetic potential of Mimosa pudica seed extract in streptozotocin-induced diabetic rats. J Diabetes Metab Disord. 2015;14:24.
  45. Khandelwal S, Singh DP, Singh S. Protective effect of Mimosa pudica leaf fraction on kidney function and oxidative stress in diabetic mice. Biomed Pharmacother. 2018;103:385–390.
  46. Thakur A, Joshi A, Chauhan NS, Dixit VK. Antifertility effects of methanolic root extract of Mimosa pudica Linn. in female albino mice. J Ethnopharmacol. 2009;124(3):563–567.
  47. Sharma R, Singh P. Seed treatment and germination improvement techniques for medicinal plants. J Herbal Agric Sci. 2021;8(2):78–85.
  48. Gupta M, Yadav S. Soil and climatic factors influencing growth of Mimosa pudica. Int J Plant Sci. 2020;12(1):45–51.
  49. Patel R, Joshi V. Cultivation practices for medicinal herbs in tropical regions. Herbal Res J. 2022;10(4):120–128.
  50. Kumar S, Singh D. Propagation and field management of Mimosa pudica for sustainable use. Agric Sci Rev. 2019;15(3):200–207.
  51. Rao A, Das N. Integrated pest management in medicinal plant cultivation. J Plant Protect Sci. 2020;16(1):30–37.
  52. Mehta K, Sharma N. Post-harvest processing and storage of medicinal herbs. Phytomed J. 2021;7(2):95–102.

Photo
Vrushabh Patil
Corresponding author

D. Y. Patil Education Society (Deemed to Be University) D. Y. Patil College of Pharmacy Kadamwadi Kolhapur, Maharashtra.

Photo
Dr. Chandraprabhu Jangme
Co-author

D. Y. Patil Education Society (Deemed to Be University) D. Y. Patil College of Pharmacy Kadamwadi Kolhapur, Maharashtra.

Photo
Dr. Sundeep Kadasi
Co-author

D. Y. Patil Education Society (Deemed to Be University) D. Y. Patil College of Pharmacy Kadamwadi Kolhapur, Maharashtra.

Photo
Shubham Patil
Co-author

D. Y. Patil Education Society (Deemed to Be University) D. Y. Patil College of Pharmacy Kadamwadi Kolhapur, Maharashtra.

Photo
Aishwarya Kholkumbe
Co-author

D. Y. Patil Education Society (Deemed to Be University) D. Y. Patil College of Pharmacy Kadamwadi Kolhapur, Maharashtra.

Photo
Dr. Rameshwar Ardad
Co-author

D. Y. Patil Education Society (Deemed to Be University) D. Y. Patil College of Pharmacy Kadamwadi Kolhapur, Maharashtra.

Dr. Chandraprabhu Jangme, Dr. Sundeep Kadasi, Dr. Rameshwar Ardad, Vrushabh Patil*, Aishwarya Kholkumbe, Shubham Patil, The Shy Healer: Exploring the Ethnopharmacology, Phytochemicals, and Biomedical Applications of Mimosa Pudica L., Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 21-34. https://doi.org/10.5281/zenodo.15779875

More related articles
Polyherbal Churn For Treatment Of Diabetes...
Tushar Sanjay Bochare, Nishan Bobade , Vedant Sanjay Ganorkar , V...
Insilico Studies On Herbal Phytoconstituents For T...
Umarani Savita Bhimashankar, H. M. Mallikarjuna, Meghana H. E. , ...
A Review on Murraya Koenigii: Multipotential Medicinal Plant...
Pragati Bhalerao, Dr. Manojkumar Mahajan, Dr. Aman Upaganlawar, Dr. Chandrashekhar Upasani, Shreya W...
An Analysis Of The Effect Of Naturopathy And Ayurveda On Cystic Fibrosis ...
Rutuja Damodhar Amle, Ravindra Mapari , Harshal Sudhakar Lahane . , Yogesh Bhagwan Katkar, Vitthal G...
Related Articles
Evaluation Of Protective Effect of Ethanolic Extract Of “Nelumbo Nucifera” L...
Surabhi M, Nayana Shaji, Anumol George, Sri. SUKU J, ...
Analytical Method Development And Validation For Simultaneous Estimation Of Anti...
Kartik A. Bhatkar, V. M. Waghulkar, M. P. Jadhao, M. D. Game, S. G. Jawarkar, ...
Novel Thiazole Substituted Imidazolin-5-ones: Synthesis, Biological Screening an...
Vanshika Deo , Dr. Alex Joseph, Dr. Angel Treasa Alex, ...
More related articles
Polyherbal Churn For Treatment Of Diabetes...
Tushar Sanjay Bochare, Nishan Bobade , Vedant Sanjay Ganorkar , Vaishnavi Chavhan, Ashweeni Kedar, ...
Insilico Studies On Herbal Phytoconstituents For The Treatment Of Covid-19: A Re...
Umarani Savita Bhimashankar, H. M. Mallikarjuna, Meghana H. E. , Muni Naga Gayathri S. , Naveenkumar...
Polyherbal Churn For Treatment Of Diabetes...
Tushar Sanjay Bochare, Nishan Bobade , Vedant Sanjay Ganorkar , Vaishnavi Chavhan, Ashweeni Kedar, ...
Insilico Studies On Herbal Phytoconstituents For The Treatment Of Covid-19: A Re...
Umarani Savita Bhimashankar, H. M. Mallikarjuna, Meghana H. E. , Muni Naga Gayathri S. , Naveenkumar...